Skip to main content

Table 3 Serum apoA-I levels in male and female NMO, ATM patients and healthy controls

From: Distinct serum apolipoprotein A-I levels in neuromyelitis optica and acute transverse myelitis

 

Female

ApoA-I (g/L)

Male

ApoA-I(g/L)

p1

p2

p3

Age

Age

NMO

38.1 ± 13.2

1.21 ± 0.23

38.5 ± 17.3

1.17 ± 0.17

0.001*a

0.002*a

0.471

ATM

39.8 ± 16.1

1.43 ± 0.22

38.6 ± 16.4

1.34 ± 0.19

0.001*b

<0.001**b

0.056

HC

39.3 ± 18.7

1.67 ± 0.21

42.5 ± 16.8

1.52 ± 0.16

<0.001**c

<0.001**c

<0.001**

  1. Data are means ± SD. p1, Compared serum apoA-I levels among three female groups; p2, Compared serum apoA-I levels among three male groups; aNMO versus ATM; bATM versus HC; cNMO versus HC; p3, Compared serum apoA-I levels between female and male NMO patients, and female and male patients in other two groups.
  2. *Difference is significant below the 0.01 level.
  3. **Difference is significant below the 0.001 level.
Back to article page

Lipids in Health and Disease

ISSN: 1476-511X